Diagnostic Value of Neutrophil To Lymphocyte Ratio For Assessing The Disease Severity In Covid-19 Patients

Deterioration of the clinical condition in corona virus disease 2019 (Covid-19) patients can be rapid and unpredictable. A sensitive biomarker is required to assess the disease severity to anticipate these condition. Neutrophil to lymphocyte ratio (NLR) is easily calculated from a complete blood count parameters, so it can be used as a biomarker to assess disease severity in Covid-19 patients. Patients characteristic and NLR were obtained from patients confirmed by Covid-19 at Udayana University Hospital, Bali, Indonesia from April to September 2020. The Mann Whitney U test is used to determine the difference of NLR in severe and non-severe cases of Covid-19. The receiver operating characteristic curve (ROC) is used to determine the optimal cut-off value, sensitivity, specificity, and area under curve (AUC) of the NLR in assessing disease severity in Covid-19 patients. Binary logistic regression analysis was performed to determine the effect of age, comorbidities and other significant variables that have a significant effect on disease severity. A total of 411 patients were included in this study. We found a significant difference of NLR between severe and non-severe cases of Covid-19 (p < 0.001). We found an optimal NLR cut-off value of 3.0, with 81.4% sensitivity, 81.2% specificity, and area under curve of 0.886 (95% confidence interval (CI) 0.848 – 0.923; p < 0.001). Neutrophil to lymphocyte ratio is a biomarker that has a high diagnostic value for assessing the disease severity in Covid-19 patients.

PDF

___

1. World health Organization. Coronavirus disease (COVID-19) Pandemic. Published September 30, 2020. Accessed September 30, 2020. https://www.who.int/emergencies/diseases/nov el-coronavirus-2019

2. World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020. World Health Organization. 2020.

3. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506.

4. Li T, Lu H, Zhang W. Clinical observation and management of COVID-19 patients. Emerg Microbes Infect 2020; 9: 687-690.

5. Liao YC, Liang WG, Chen FW, Hsu JH, Yang JJ, Chang MS. IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha. J Immunol 2002; 169: 4288-4297.

6. Channappanavar R. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. In: Channappanavar R, Perlman S. Seminars in immunopathology. Springer Berlin Heidelberg 2017; 529-539.

7. Guan WJ, Ni ZY, Hu Y. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020; 382: 1708-1720.

8. Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H, Xiong Y, Cheng Z, Gao S, Liang K, Luo M. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis. 2020. [Epub ahead of print].

9. Sun S, Cai X, Wang H, He G, Lin Y, Lu B, et al. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China. Clinica Chimica Acta 2020; 507: 174-180.

10. Menges T, Engel J, Welters I, Wagner RM, Little S, Ruwoldt R, et al. Changes in blood lymphocyte populations after multiple trauma: association with post traumatic complications. Crit Care Med 1999; 27: 733-740.

11. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395: 507-513.

12. Kusumanto YH, Dam WA, Hospers GA, Meijer C, Mulder NH. Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis 2003; 6: 283-287.

13. Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology 2002; 16: 217-232.

14. Faria SS, Fernandes PJ, Silva MJ. The neutrophilto- lymphocyte ratio: a narrative review. Ecancermedicalscience 2016; 10: 702.

15. Liu Y, Du X, Chen J, Jin Y, Peng L, Wang, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. Journal of Infection 2020; 81: 6- 12.

16. Naess A, Nilssen SS, Mo R, Eide GE, Sjursen H. Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever. Infection 2017; 45: 299-307.

17. Ying HQ, Deng QW, He BS, Pan YQ, Wang F, Sun HL et al., The prognostic value of preoperative NLR, d- NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients. Med Oncol 2014; 31: 305.

18. Shimoyama Y, Umegaki O, Inoue S, Agui T, Kadono N, and Minami T. The neutrophil to lymphocyte ratio is superior to other inflammation-based prognostic scores in predicting the mortality of patients with pneumonia. Acta Med Okayama 2018; 72: 591- 593.

19. Uslu AU, Ku c u k A, S ahin A, Ugan Y, Yilmaz R, Gu ngo r T, et al., Two new inflammatory markers associated with Disease Activity Score-28 in patients with rheumatoid arthritis: neutrophillymphocyte ratio and platelet-lymphocyte ratio. Int J Rheum Dis 2015; 18: 731-735.

20. Jeon YL, Lee WI, Kang SY, Kim MH. Neutrophil-to-monocyte-plus-lymphocyte ratio as a potential marker for discriminating pulmonary tuberculosis from non-tuberculosis infectious lung diseases. Laboratory medicine 2019; 50: 286- 291.

21. Yang, AP, Liu J, Tao W, Li HM. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. International immunopharmacology 2020; 84: e106504.